Search
Pimivalimab
go.drugbank.com/drugs/DB16667InvestigationalPimivalimab is under investigation in clinical trial NCT04549025 (Study of PD-1 Inhibitor JTX-4014 Alone and in Combination With Vopratelimab in Biomarker-selected Subjects With Metastatic NSCLC After
Marbofloxacin
go.drugbank.com/drugs/DB11426ExperimentalVet approvedA formulation of marbofloxacin combined with clotrimazole and dexamethasone is available under the name Aurizon.
Nizaracianine
go.drugbank.com/drugs/DB21517InvestigationalNizaracianine is under investigation in clinical trial NCT05752149 (Fluorescence-guided Surgery in Laryngeal- and Hypopharyngeal Cancer: a Feasibility Trial).
Lintopride
go.drugbank.com/drugs/DB20532ExperimentalThe usage of the INN stem '-pride' in the name indicates that Lintopride is a sulpiride derivative and analogue. Lintopride has a monoisotopic molecular weight of 310.12 Da.
Lirexapride
go.drugbank.com/drugs/DB20963ExperimentalThe usage of the INN stem '-pride' in the name indicates that Lirexapride is a sulpiride derivative and analogue. Lirexapride has a monoisotopic molecular weight of 433.25 Da.
3-Fluoro-L-tyrosine
go.drugbank.com/drugs/DB04436ExperimentalThis compound belongs to the phenylpropanoic acids. … These are compounds whose structure contain a benzene ring conjugated to a propanoic acid. 3-Fluoro-L-tyrosine targets the protein superoxide dismutase [mn], mitochondrial.
Elzasonan
go.drugbank.com/drugs/DB18969InvestigationalElzasonan is under investigation in clinical trial NCT00275197 (A Research Study to Compare the Treatments of a Combination of Elzasonan With Zoloft, to Zoloft Alone, or Placebo in People With Major Depressive
Opaviraline
go.drugbank.com/drugs/DB07884ExperimentalCategories: Non-Nucleoside Reverse Transcriptase InhibitorsBMS-986141
go.drugbank.com/drugs/DB14942InvestigationalBMS-986141 is under investigation in clinical trial NCT02985632 (A Study to Evaluate the Pharmacokinetics of BMS-986141 in Participants With Hepatic Impairment Compared to Healthy Participants).
Miransertib
go.drugbank.com/drugs/DB14982InvestigationalMiransertib is under investigation in clinical trial NCT01473095 (Phase 1 Dose Escalation Study of ARQ 092 in Adult Subjects With Advanced Solid Tumors and Recurrent Malignant Lymphoma).